In this study, we want to learn more about the safety and effectiveness of using a personalized vaccine with a drug called pembrolizumab for the treatment of non‐small cell lung cancer (NSCLC) and squamous cell cancer of the head and neck (SCCHN).

Have you been diagnosed with small cell lung cancer? Is your current treatment no longer working in controlling your cancer? If so, you may be able to take part in a research study looking at giving trilaciclib to help minimize the side effects of lurbinectedin.

We are doing a research study of people who both smoke and vape. The purpose of this study is to learn more about your opinions on health messages.

This is a Phase III study to help us improve outcomes of patients with ER+/HER2- early breast cancer with intermediate or high risk for disease recurrence. This study is for patients who have completed definitive locoregional therapy and standard adjuvant endocrine therapy for at least 2 years and up to 5 years without disease recurrence. In this study, we want to learn if a new oral "SERD" therapy called Camizestrant is helpful in reducing chance of recurrence. Talk to your Medical Oncologist for more information about this trial.

This is a research study to investigate how collecting information about treatment-related side effects directly from patients can help manage the side effects associated with certain oral chemotherapies in patients with metastatic renal cell carcinoma.

If you or your child has been diagnosed with any cancer, you or your child may be able to take part in this study. This study will collect and store samples from you or your child so that researchers can use these samples and learn more about the disease.

In this study, we want to learn if existing services meet the needs of people who experience crime in North Carolina. Specifically, we will focus on whether these services meet the needs of crime victims from historically underserved populations. We also want to learn whether service accessibility is different across the state. Although the assessment is meant to cover all North Carolinians, the GCC and research team have identified specific priority populations, including: veterans, immigrants, refugees, people with disabilities, older adults, LGBTQ+ individuals, teens, people from religious minority groups, people who are unhoused/experiencing homelessness, co-victims of homicide, indigenous communities, people with limited English proficiency, and people of color.

In this study, we want to find out more about how adults learn a second language, specifically how native speakers of America English learn Russian.

If you or your child has been diagnosed with acute lymphoblastic leukemia (ALL), you or they might be able to take part in a research study. This study aims to understand why there are differences in outcomes in adolescents and young adults treated for ALL.

In this study, we want to learn more about how stress related to COVID-19 can affect behaviors and the way that genes work (epigenetics) in healthcare workers. This study focuses on healthcare workers because they are in the frontline of the pandemic.